- Home
- NUVB vs SSYS Comparison
NUVB vs SSYS Comparison
Compare NUVB & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- SSYS
- Stock Information
- Founded
- NUVB 2018
- SSYS 1989
- Country
- NUVB United States
- SSYS United States
- Employees
- NUVB N/A
- SSYS N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- NUVB Health Care
- SSYS Technology
- Exchange
- NUVB Nasdaq
- SSYS Nasdaq
- Market Cap
- NUVB 1.1B
- SSYS 942.7M
- IPO Year
- NUVB N/A
- SSYS 1994
- Fundamental
- Price
- NUVB $3.28
- SSYS $9.84
- Analyst Decision
- NUVB Strong Buy
- SSYS Strong Buy
- Analyst Count
- NUVB 6
- SSYS 3
- Target Price
- NUVB $8.17
- SSYS $14.33
- AVG Volume (30 Days)
- NUVB 6.7M
- SSYS 957.4K
- Earning Date
- NUVB 11-05-2025
- SSYS 11-12-2025
- Dividend Yield
- NUVB N/A
- SSYS N/A
- EPS Growth
- NUVB N/A
- SSYS N/A
- EPS
- NUVB N/A
- SSYS N/A
- Revenue
- NUVB $14,355,000.00
- SSYS $564,499,000.00
- Revenue This Year
- NUVB $332.80
- SSYS N/A
- Revenue Next Year
- NUVB $360.12
- SSYS $3.06
- P/E Ratio
- NUVB N/A
- SSYS N/A
- Revenue Growth
- NUVB 900.35
- SSYS N/A
- 52 Week Low
- NUVB $1.54
- SSYS $6.92
- 52 Week High
- NUVB $4.09
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- NUVB 58.18
- SSYS 41.46
- Support Level
- NUVB $3.20
- SSYS $9.66
- Resistance Level
- NUVB $3.41
- SSYS $10.05
- Average True Range (ATR)
- NUVB 0.27
- SSYS 0.36
- MACD
- NUVB -0.03
- SSYS -0.05
- Stochastic Oscillator
- NUVB 33.55
- SSYS 12.09
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.